Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-25-002371
Filing Date
2025-01-29
Accepted
2025-01-29 19:00:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7690
  Complete submission text file 0001140361-25-002371.txt   9472
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Subject) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91300 | Film No.: 25570637
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O EXAGEN INC. 1261 LIBERTY WAY, SUITE C VISTA CA 92081
Business Address C/O EXAGEN INC. 1261 LIBERTY WAY, SUITE C VISTA CA 92081 (760) 560-1501
NMSIC Co-Investment Fund, L.P. (Filed by) CIK: 0001788331 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A